1. Adriamycin: amelioration of toxicity by alpha-tocopherol;Myers;Cancer Treat Rep,1976
2. Reduction of chronic doxorublcin cardiotoxicity in dogs by pretreatment with (+)-1,2-bis (3,5-dioxopiperazinyl-1-yl) propane (ICRF-187);Herman;Cancer Res,1981
3. Prevention of the cardiotoxic effects of Adriamycin and daunomycin in the isolated dog heart;Herman,1972
4. N-trifluoracetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than Adriamycin;Israel;Cancer Res,1975
5. Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4′-epiadriamycin;DiMarco;Cancer Treat Rep,1978